The high-profile trial of former Theranos CEO Elizabeth Holmes boils down to a single question: Did she cover up defects in her startup’s blood-testing technology to rip off investors while potentially endangering the lives of unwitting patients
Related posts
-
A medical plane carrying a child patient and 5 others crashes in Philadelphia, setting homes ablaze
PHILADELPHIA -- A medical transport jet with a child patient, her mother and four others aboard... -
Illinois clean energy leaders strategize in wake of Trump orders: ‘Make this about consumers’
A roundtable hosted by U.S. Rep. Sean Casten on Friday offered a sneak peek at strategies... -
Aurora police ask for help locating man wanted for shooting, killing 82-year-old
Aurora police are asking for the public’s help in locating a man wanted for the New...